Methylphenidate substitution for methamphetamine addiction and implications for future randomized clinical trials: a unique case series

References

• Brensilver, M., Heinzerling, K. G., & Shoptaw, S. (2013). Pharmacotherapy of amphetamine-type stimulant dependence: An update. Drug and Alcohol Review, 32, 449–460
   PubMed Web of Science ®Google Scholar
• Brenza, J., & Gabrhelík, R. (2014). Use of opioid and stimulant medications in the Czech Socialist Republic before the “discovery” of the clandestine manufacturing of locally-specific stimulants and opiates. Adiktologie, 14, 284–293
   Google Scholar
• Ciketic, S., Hayatbakhsh, M. R., Doran, C. M., Najman, J. M., & McKetin, R. (2012). A review of psychological and pharmacological treatment options for methamphetamine dependence. Journal of Substance Use, 17, 363–383
   Web of Science ®Google Scholar
• Gabrhelík, R., Šťastná, L., Holcnerová, P., & Miovský, M. (2010). Aktuální otázky léčby závislosti na metamfetaminu. Adiktologie, 10, 92–100
   Google Scholar
• Griffiths, P., Mravčík, V., Lopez, D., & Klemopva, D. (2008). Quite a lot of smoke but very limited fire-the use of methamphetamine in Europe. Drug and Alcohol Review, 27, 236–242
   PubMed Web of Science ®Google Scholar
• Hampl, K. (2004). Substituční léčba závislosti na pervitinu. Česká a Slovenská Psychiatrie, 100, 274–278
   Google Scholar
• Kay-Lambkin, F. J. (2008). Technology and innovation in the psychosocial treatment of methamphetamine use, risk and dependence. Drug and Alcohol Review, 27, 318–325
   PubMed Web of Science ®Google Scholar
• Konstenius, M., Jayaram-lindstrom, N., Beck, O., & Franck, J. (2010). Sustained release methylphenidate for the treatment of ADHD in amphetamine abusers: A pilot study. Drug and Alcohol Dependence, 108, 130–133
   PubMed Web of Science ®Google Scholar
• Lee, N. K., & Rawson, R. A. (2008). A systematic review of cognitive and behavioural therapies for methamphetamine dependence. Drug and Alcohol Review, 27, 309 –317
   PubMed Web of Science ®Google Scholar
• Ling, W., Chang, L., Hillhouse, M., Ang, A., Striebel, J., Jenkins, J., Hernandez, J., Olaer, M., Mooney, L., Reed, S., Fukaya, E., Kogachi, S., Alicata, D., Holmes, N. & Esagoff, A. (2014). Sustained-release methylphenidate in a randomized trial of treatment of methamphetamine use disorder. Addiction, 109, 1489–1500
   PubMed Web of Science ®Google Scholar
• Miles, S. W., Sheridan, J., Russell, B., Kydd, R., Wheeler, A., Walters, C., Gamble, G., Hardley, P., Jensen, M., Kuoppasalmi, K., Tuomola, P., Föhr, J., Kuikanmäki, O., Vorma, H., Salokangas, R., Mikkonen, A., Kallio, M., Kauhanen, J., Kiviniemi, V., & Tiihonen, J. (2013). Extended-release methylphenidate for treatment of amphetamine/methamphetamine dependence: A randomized, double-blind, placebo-controlled trial. Addiction, 108, 1279–1286
   PubMed Web of Science ®Google Scholar
• Minařík, J., & Gabrhelík, R. (2011). Farmakoterapie závislosti na metamfetaminu. Adiktologie, 11, 48–52
   Google Scholar
• Moss, R., & Munt, B. (2003). Injection drug use and right sided endocarditis. Heart, 89, 577–581
   PubMed Web of Science ®Google Scholar
• Mounteney, J., Groshkova, T., Thanki, D., Cunningham, A., & Rychert, M. (2014). Exploring methamphetamine trends in Europe. European Monitoring Centre for Drugs and Drug Addiction. Available from: http://www.emcdda.europa.eu/publications/emcdda-papers/exploring-methamphetamine-trends-in-Europe [last accessed 15 Jun 2014]
   Google Scholar
• Mravčík, V., Chomynová, P., Grohmannová, K., Nečas, V., Grolmusová, L., Kiššová, L., Nechanská, B., Sopko, B., Fidesová, H., Vopravil, J., & Jurystová, L. (2014). Annual Report on Drug Situation 2013 – Czech Republic. Praha: Úřad vlády České republiky
   Google Scholar
• Mravčík, V., Škařupová, K., Orlíková, B., Zábranský, T., Karachaliou, K., & Schulte, B. (2011). Use of gelatine capsules for application of methamphetamine: A new harm reduction approach. International Journal of Drug Policy, 22, 172–173
   PubMed Web of Science ®Google Scholar
• Nelson, P. K., Mathers, B. M., Cowie, B., Hagan, H., Des Jarlais D., Horyniak, D., & Degenhardt, L.J. (2011). Global epidemiology of hepatitis B and hepatitis C in people who inject drugs: Results of systematic reviews. Lancet, 378, 571–583
   PubMed Web of Science ®Google Scholar
• Pates, R., Coombes, R., & Ford, N. (1996). A pilot programme in prescribing dexamphetamine for amphetamine users (part I). Journal of Substance Use, 1, 80–84
   Google Scholar
• Pérez-Mañá, C., Castells, X., Torrens, M., Capellà, D., & Farre, M. (2012). Efficacy of psychostimulant drugs for amphetamine abuse or dependence. Cochrane Database of Systematic Reviews, 3. doi: 10.1002/14651858.CD009695
   Google Scholar
• Tiihonen J., Kuoppasalmi K., Fohr J., Tuomola P., Kuikanmaki O., Vorma H., et al. (2007). A comparison of aripiprazole, methylphenidate, and placebo for amphetamine dependence. Am J Psychiatry, 164, 160–162
   PubMed Web of Science ®Google Scholar
• UNAIDS (2009). HIV Prevention among injecting drug users. Available from: http://data.unaids.org/pub/InformationNote/2009/20090518_hiv_prevention_among_idus_final_en.pdf. (accessed March 2015)
   Google Scholar
• Vacek, J., Gabrhelík, R., Novák, D., Brendryen, H., & Burda, V. (in press). Use of Information Technology in Relapse Prevention in Methamphetamine Dependent Patients: Development of Tools for the Detection of Craving Using Smartphones. Adiktologie, in press
   Google Scholar
• Wodak, A., & McLeod, L. (2008). The role of harm reduction in controlling HIV among injecting drug users. AIDS, 22, S81–S92
   PubMed Web of Science ®Google Scholar
• Zábranský, T. (2007). Methamphetamine in the Czech Republic. Journal of Drug Issues, 37, 155–180
   Web of Science ®Google Scholar